Form 4: LeonaBio GC Sells Shares for Tax After RSU Vesting
Insider Transaction Report
LeonaBio's General Counsel, Mark Worthington, sold 1,328 shares of common stock to cover tax obligations following the vesting of 5,726 restricted stock units.
Summary
- Mark Worthington, General Counsel and CCO of LeonaBio, Inc. (LONA), reported transactions related to his beneficial ownership.
- On March 3, 2026, 5,726 Restricted Stock Units (RSUs) vested, converting into 5,726 shares of common stock. These RSUs were granted on March 3, 2025, and adjusted for a 10-for-1 reverse stock split on September 17, 2025.
- Following the vesting, Mr. Worthington's direct beneficial ownership increased to 19,704 shares.
- On March 4, 2026, Mr. Worthington sold 1,328 shares of common stock at a weighted-average price of $5.37 per share.
- This sale was a mandatory "sell to cover" transaction to satisfy tax withholding and remittance obligations associated with the RSU vesting and was not a discretionary sale.
- After the sale, Mr. Worthington's direct beneficial ownership stands at 18,376 shares.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event. The RSU vesting is a positive for the executive, but the subsequent tax-related sale is a standard, non-discretionary transaction that does not signal a change in company fundamentals or insider sentiment.
Positives
- The vesting of 5,726 Restricted Stock Units (RSUs) indicates the achievement of performance or time-based conditions, reflecting continued employment and potential contribution of the General Counsel.
- The transaction was a non-discretionary "sell to cover" for tax purposes, not a voluntary sale, which can be viewed more favorably than a discretionary insider sale.
Negatives
- The sale of 1,328 shares, even for tax purposes, results in a reduction of the insider's direct beneficial ownership in the company.
Future Outlook
NA
Industry Context
StockSavvy.ai notes that routine insider transactions, such as RSU vesting followed by a 'sell to cover' for tax purposes, are common occurrences in publicly traded companies, particularly for executives receiving equity compensation. These transactions are generally not indicative of broader industry trends but rather reflect standard compensation practices.
Related Party Transactions
- The vesting of Restricted Stock Units (RSUs) and subsequent "sell to cover" transaction by Mark Worthington, an officer of LeonaBio, Inc., constitutes a related party transaction as it involves an insider's compensation and share dealings with the company.
Stakeholder Impact
- Shareholders: The sale of shares, even for tax purposes, slightly reduces the overall insider ownership percentage. However, the vesting of RSUs indicates continued alignment of executive interests with shareholder value.
- Employees: The RSU vesting demonstrates the company's commitment to equity-based compensation for its executives.
Key Dates
| Date | Description |
|---|---|
| 2025-03-03 | Grant date of 5,726 Restricted Stock Units (RSUs) to Mark Worthington. |
| 2025-09-17 | Completion of a 10-for-1 reverse stock split, which adjusted the number of RSUs. |
| 2026-03-03 | Vesting date of 5,726 RSUs and acquisition of common stock by Mark Worthington. |
| 2026-03-04 | Sale of 1,328 shares of common stock by Mark Worthington to cover tax obligations. |
| 2026-03-05 | Signature date of the Form 4 filing. |
Recommendation
holdThis Form 4 filing details a routine, non-discretionary transaction by an insider related to equity compensation. The vesting of RSUs and subsequent 'sell to cover' for tax purposes is a standard event and does not provide new information that would warrant a change in investment thesis or a strong buy/sell recommendation. It is a neutral event for the stock's fundamental outlook.
Keywords
LeonaBio, LONA, Form 4, insider transaction, Mark Worthington, Restricted Stock Units, RSU vesting, sell to cover, common stock, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.